Fenbendazole
If you find any inaccurate information, please let us know by providing your feedback here

Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
C15H13N3O2S 299.35
Carbamic acid, [5-(phenylthio)-1H-benzimidazol-2-yl]-, methyl ester;
Methyl 5-(phenylthio)-2-benzimidazolecarbamate CAS RN®: 43210-67-9; UNII: 621BVT9M36.
1 DEFINITION
Fenbendazole contains NLT 98.0% and NMT 101.0% of fenbendazole (C15H13N3O2S), calculated on the dried basis.
2 IDENTIFICATION
Change to read:
A. SPECTROSCOPIC IDENTIFICATION TESTS (197), Infrared Spectroscopy: 1974, 197K, or 197M (CN 1-May-2020)
3 ASSAY
3.1 PROCEDURE
Sample: 200 mg
Analysis: Dissolve the Sample in 30 mL of glacial acetic acid, warming if to effect solution. Allow to cool, and titrate with 0.1 N perchloric acid VS, determining the endpoint potentiometrically. Each mL of 0.1 N perchloric acid is equivalent to 29.94 mg of fenbendazole (C15H13N3O2S).
Acceptance criteria: NLT 98.0%-101.0% on the dried basis
4 IMPURITIES
4.1 RESIDUE ON IGNITION (281)
NMT 0.3%
4.2 ORGANIC IMPURITIES
Solution A: Methanol, acetic acid, and water ( 30:1:70)
Solution B: Methanol, acetic acid, and water (70:1:30)
Mobile phase: See Table 1.
Table 1
| Time (min) | Solution A (%) | Solution B (%) |
| 0 | 100 | 0 |
| 10 | 0 | 100 |
| 40 | 0 | 100 |
| 50 | 100 | 0 |
Diluent: Methanol and hydrochloric acid (99:1)
System suitability stock solution: 0.1 mg/mL each of USP Fenbendazole RS and USP Mebendazole RS in methanol
System suitability solution: 0.01 mg/mL each of USP Fenbendazole RS and USP Mebendazole RS from the System suitability stock solution in Diluent
Standard stock solution A: 0.025 mg/mL of USP Fenbendazole RS prepared as follows. Dissolve a weighed quantity of USP Fenbendazole RS in Diluent to obtain a solution with a known concentration of 5 mg/mL. Dilute 1.0 mL of this solution with methanol to 200.0 mL.
Standard solution A: 0.0125 mg/mL of USP Fenbendazole RS from Standard stock solution A in Diluent
Standard stock solution B: 0.1 mg/mL of USP Fenbendazole Related Compound A RS in methanol
Standard solution B: 0.01 mg/mL of USP Fenbendazole Related Compound A RS from Standard stock solution B in Diluent
Standard stock solution C: 0.1 mg/mL of USP Fenbendazole Related Compound B RS in methanol
Standard solution C: 0.01 mg/mL of USP Fenbendazole Related Compound B RS from Standard stock solution C in Diluent
Sample solution: Dissolve 5.0 mg/mL of Fenbendazole in Diluent.
Chromatographic system
(See Chromatography (621), System Suitability.)
Mode: LC
Detector: UV 280 nm
Column: 4.6-mm x 25-cm; 5-µm packing L1
Flow rate: 1 mL/min
Injection volume: 10 µL
System suitability
Sample: System suitability solution
[NOTE-The relative retention times for mebendazole and fenbendazole are about 0.85 and 1.0, respectively.]
Suitability requirements
Resolution: NLT 1.5 between mebendazole and fenbendazole
Analysis
Samples: Standard solution A, Standard solution B, Standard solution C, and Sample solution
Calculate the percentages of fenbendazole related compound A and fenbendazole related compound B in the portion of Fenbendazole taken:
Result = (rU/rS) x (CS/CU) x 100
rU = peak response of each related compound from the Sample solution
rS = peak response of the corresponding related compound from Standard solution B or Standard solution C
CS = concentration of the corresponding related compound in Standard solution B or Standard solution C (mg/mL)
CU = concentration of Fenbendazole in the Sample solution (mg/mL)
Calculate the percentage of any other impurity in the portion of Fenbendazole taken:
Result = (rU/rS) x (CS/CU) x 100
rU = peak response of any impurity from the Sample solution
rS = peak response of USP Fenbendazole RS from Standard solution A
CS = concentration of USP Fenbendazole RS in Standard solution A (mg/mL)
CU = concentration of Fenbendazole in the Sample solution (mg/mL)
Acceptance criteria: See Table 2. The reporting level for impurities is 0.1%.
Table 2
| Name | Relative Retention Time | Acceptance Criteria, NMT (%) |
| Fenbendazole related compound A | 0.25 | 0.5 |
| Fenbendazole related compound B | 0.65 | 0.5 |
| Fenbendazole | 1.0 | — |
| Any individual impurity | — | 0.5 |
| Total impurities | — | 1 |
5 SPECIFIC TESTS
LOSS ON DRYING (731)
Analysis: Dry at 100°-105° for 3 h.
Acceptance criteria: NMT 1.0%
6 ADDITIONAL REQUIREMENTS
6.1 PACKAGING AND STORAGE
Preserve in well-closed, light-resistant containers, and store at room temperature.
6.2 LABELING
Label to indicate that it is for veterinary use only.
6.3 USP REFERENCE STANDARDS (11).\
USP Fenbendazole RS
USP Fenbendazole Related Compound A RS
Methyl (1H-benzimidazole-2-yl)carbamate.
C9H9N3O2 191.19
USP Fenbendazole Related Compound B RS
Methyl [5(6)-chlorobenzimidazole-2-yl]carbamate.
C9H8ClN3O2 225.63
USP Mebendazole RS

